Biogen taps digital therapeutics biotech for music-based therapy to help people with MS improve their walking

In the past decade, digital healthcare has been getting big — and now it’s saddling up with Big Pharma. As the latest pharma to take a swing at digital therapy, Biogen has licensed an investigational prescription therapy meant to help patients with multiple sclerosis (MS) improve their gait from MedRhythms, a Portland, ME-based biotech.